News & Events about Maravai Lifesciences Holdings Inc.
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2022 financial and operating results after the market ...
Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI Get Rating) have been given a consensus recommendation of Moderate Buy by the ten analysts that are covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and six...
Ticker Report
2 months ago
Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI Get Rating) have earned a consensus recommendation of Moderate Buy from the seven research firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and...
Dupont Capital Management Corp decreased its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI Get Rating) by 39.3% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 25,463 shares of the companys stock after selling 16,506 shares ...
Cerity Partners LLC acquired a new stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI Get Rating) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 24,082 ...